Use of synthetic oxygen carriers to facilitate oxygen delivery
US5344393A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Feb 28, 1992 |
| Grant date | Sep 6, 1994 |
| Priority date | — |
| Expiry date | Feb 28, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2202/0476
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for facilitating autologous blood use by a patient facing a loss of blood, comprising the steps of removing and preferably storing a portion of the patient's blood, intravenously administering a biocompatible liquid in sufficient quantity to substantially maintain the patient's hemodynamic stability, wherein the liquid comprises an effective oxygen-delivery enhancing amount of a biocompatible synthetic oxygen carrier, after which the patient undergoes a loss of blood, and then readministering blood to the patient, preferably the stored blood. In one embodiment, the biocompatible liquid further comprises a hemodiluent and the hemodiluent is administered separately from the oxygen carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.